Liminal BioSciences Inc. Debt to Equity Ratio 2017-2023 | LMNL
Current and historical debt to equity ratio values for Liminal BioSciences Inc. (LMNL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Liminal BioSciences Inc. debt/equity for the three months ending June 30, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-06-30 | $0.01B | $0.02B | 0.48 |
| 2023-03-31 | $0.01B | $0.02B | 0.35 |
| 2022-12-31 | $0.01B | $0.03B | 0.39 |
| 2022-09-30 | $0.01B | $0.03B | 0.33 |
| 2022-06-30 | $0.04B | $0.01B | 3.02 |
| 2022-03-31 | $0.04B | $0.02B | 2.31 |
| 2021-12-31 | $0.07B | $0.03B | 2.72 |
| 2021-09-30 | $0.08B | $0.04B | 2.09 |
| 2021-06-30 | $0.09B | $-0.03B | -3.19 |
| 2021-03-31 | $0.08B | $-0.00B | -20.13 |
| 2020-12-31 | $0.08B | $0.01B | 6.85 |
| 2020-09-30 | $0.07B | $0.02B | 3.28 |
| 2020-06-30 | $0.05B | $0.03B | 1.44 |
| 2020-03-31 | $0.05B | $0.05B | 0.90 |
| 2019-12-31 | $0.05B | $0.07B | 0.74 |
| 2019-09-30 | $0.06B | $0.08B | 0.71 |
| 2019-06-30 | $0.05B | $0.10B | 0.53 |
| 2019-03-31 | $0.17B | $-0.06B | -2.67 |
| 2018-12-31 | $0.13B | $-0.05B | -2.63 |
| 2018-09-30 | $0.15B | $0.05B | 3.16 |
| 2018-06-30 | $0.14B | $0.07B | 1.96 |
| 2018-03-31 | $0.13B | $0.10B | 1.33 |
| 2017-12-31 | $0.11B | $0.11B | 0.98 |
| 2017-09-30 | $0.10B | $0.14B | 0.70 |
| 2017-06-30 | $0.09B | $0.10B | 0.94 |
| 2017-03-31 | $0.08B | $0.12B | 0.65 |
| 2016-12-31 | $0.08B | $0.12B | 0.67 |
| 2016-09-30 | $0.07B | $0.11B | 0.62 |
| 2016-06-30 | $0.07B | $0.14B | 0.48 |
| 2016-03-31 | $0.07B | $0.10B | 0.65 |
